Could a Blood Test Revolutionize Multiple Sclerosis Diagnosis?

MS is an autoimmune disease that affects nearly 1 million people in the United States and 2.8 million worldwide.

MS-specific IgG in Xiaoli Yu f PhD s into large aggregates that are toxic to immunoglobulin G te IgG s accuracy offers a pat Yu to monitoring patient response to different the 90% ies and could inform futu MS treatment decisions. SPMS MS Yu d_highLightText__NxlGi">Yuthe Department of Neurosurgery d_hi the University of Colorado School of Medicine summaryFeed_highLightText__NxlGi">MS Clinical Immunology yFeed_highLightText__NxlGi">190 Cell Death & Disease __NxlGi">ELISAIgG MS MS summaryFeed_highLightText__NxlGi">MSnearly 1 million s="summaryF the United States __Nxl 2.8 million n> SPMS MS< Yu pan> RRMS between the ages of 20 and 40 summaryFeed_highLightText__NxlGi">fo MS 50 IgG NfL >Yu GFAP ghtText__NxlGi">PhD MS lGi">Xiaoli Yu MS MS